Skip to main content
SHIELD THERAPEUTICS PLC logo

SHIELD THERAPEUTICS PLC — Investor Relations & Filings

Ticker · STX ISIN · GB00BYV81293 LEI · 213800G74QWY15FC3W71 IL Manufacturing
Open in API
Filings indexed 408 across all filing types
Latest filing 2023-04-12 Report Publication Anno…
Country GB United Kingdom
Listing IL STX

About SHIELD THERAPEUTICS PLC

https://www.shieldtherapeutics.com/

Shield Therapeutics is a commercial-stage specialty pharmaceutical company focused on addressing iron deficiency. The company's mission is to improve the lives of patients suffering from this condition, with or without anemia. Its lead product is Accrufer® (ferric maltol), also marketed as Feraccru®, a novel, stable, non-salt-based oral therapy. This innovative pharmaceutical is broadly indicated for use in adults across multiple therapeutic categories, aiming to provide an effective and well-tolerated treatment for a significant unmet medical need.

Recent filings

Filing Released Lang Actions
Notice of Results
Report Publication Announcement Classification · 99% confidence The document is a formal announcement disseminated via RNS (RNS Number: 8850V) from Shield Therapeutics PLC. The title is "Notice of Results Investor Presentation". The text explicitly states that the company "will announce its final results for the year ended 31 December 2022 on Thursday 27 April 2023" and details the subsequent investor presentation event. Since the document's primary purpose is to announce the upcoming release of results and the associated presentation, it fits the definition of a Report Publication Announcement (RPA), which signals that a report (the final results) is forthcoming, rather than being the report itself (like an ER or 10-K). The document length (4734 chars) is short, supporting the RPA classification over a full report.
2023-04-12 English
Appointment of Chief Commercial Officer
Board/Management Information Classification · 98% confidence The document is identified by the RNS Number (3892V) and the header 'RNS Number : 3892V' followed by the company name and date. The content announces the 'Appointment of Chief Commercial Officer' and provides an 'Update on US salesforce expansion'. This type of announcement, concerning changes in senior management (Board/Management Information), is typically disseminated via regulatory news services. Since it is a specific announcement of management change rather than a general regulatory filing fallback (RNS) or a report itself, the most appropriate category is Board/Management Information (MANG). The document is not a full financial report (10-K, IR), an earnings release (ER), or a proxy statement (DEF 14A/PSI).
2023-04-05 English
Block Listing 6 Monthly Return
Share Issue/Capital Change Classification · 99% confidence The document begins with 'RNS Number : 8480U' and is dated March 31, 2023. The content is structured as a 'Block Listing 6 Monthly Return' detailing the balance of unallotted securities under various share schemes (Retention Share Plan, Option Plan, Incentive Plan, etc.) for the period from September 30, 2022, to March 31, 2023. The footer explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.' This format strongly indicates a routine regulatory disclosure made via the RNS system. Since this is a specific regulatory filing related to share schemes and not a general announcement (RPA) or a core financial report (10-K, IR), the most appropriate classification is the general regulatory filing category, RNS.
2023-03-31 English
Price Monitoring Extension
Regulatory Filings Classification · 99% confidence The document is very short (1921 characters) and contains the header 'RNS Number : 1191T'. It announces a 'Price Monitoring Extension' related to trading on the London Stock Exchange and explicitly states that the information is provided by RNS, the news service of the London Stock Exchange, which is approved as a Primary Information Provider. This is a general regulatory announcement that does not fit the specific categories like ER, IR, 10-K, or DIV. Therefore, it falls under the general Regulatory Filings category.
2023-03-15 English
Total Voting Rights Update
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is identified by the RNS Number (1893R) and explicitly states it is providing an update on 'Total Voting Rights' in compliance with the FCA's Disclosure and Transparency Rule 5.6.1. This rule mandates the disclosure of the total number of shares with voting rights. This type of mandatory, periodic disclosure regarding share capital structure and voting rights is a standard regulatory announcement. While it relates to share capital, it is not a transaction (POS) or a general capital change (SHA), but a mandatory disclosure of the current denominator for shareholder notifications. Since it is a specific regulatory announcement that doesn't fit perfectly into the other specific categories (like 10-K, ER, DIV), and it is explicitly branded as an RNS release from the London Stock Exchange's information provider, the most appropriate classification is the general regulatory filing category, RNS.
2023-02-28 English
Second Price Monitoring Extn
Regulatory Filings Classification · 98% confidence The document is very short (1941 characters) and contains the header 'RNS Number : 3174Q'. It announces a 'Second Price Monitoring Extension' related to trading activity on the London Stock Exchange. The text explicitly mentions 'RNS, the news service of the London Stock Exchange' and is clearly a regulatory announcement that does not fit the specific definitions for financial reports (10-K, IR, ER), management changes (MANG), or shareholder actions (AGM-R, DVA). Given its nature as a general, time-sensitive regulatory notice from the exchange's news service, the most appropriate classification is the general regulatory filing category.
2023-02-17 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.